Documentos relacionados

1. Hepatotoxicity induced by chronic suppurative otitis media in rats and effects of ceftazidime and amikacin on it.
2. Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches.
3. <i>Methylobacterium</i> infection-induced peritonitis in a patient with renal insufficiency: A case report and literature review.
4. Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings.
5. Increased expression of Mycobacterium tuberculosis Rv3737 gene associated with low-level amikacin resistance.
6. Comparing minimum inhibitory concentrations of amikacin for pulmonary Mycobacterium avium complex disease: An analysis of culture media differences.
7. Failure to predict amikacin elimination in critically ill patients with cancer based on the estimated glomerular filtration rate: applying PBPK approach in a therapeutic drug monitoring study.
8. Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia. Reply.
9. Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia.
10. Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia.